Nuclear receptors and endocrine disruptors in fetal and neonatal testes: A gapped landscape

Frontiers in Endocrinology

Volumn 6, Issue MAY, 2015, Pages

  Rouiller Fabre, Virginie ^a,b,c   Guerquin, Marie Justine ^a,b,c   N'Tumba Byn, Thierry ^a,b,c   Muczynski, Vincent ^a,b,c   Moison, Delphine ^a,b,c   Tourpin, Sophie ^a,b,c   Messiaen, Sébastien ^a,b,c   Habert, René ^a,b,c   Livera, Gabriel ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^c Universite Paris Sud   (France)

Author keywords

BPA; DES; Human fetal testis; Nuclear receptors; Phthalates

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR; LIVER X RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHTHALIC ACID;

ANDROGEN INSENSITIVITY SYNDROME; APOPTOSIS; BINDING AFFINITY; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPARATIVE STUDY; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; PREMATURE LABOR; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPRODUCTION; REVIEW; SEXUAL MATURITY; SIGNAL TRANSDUCTION; SPERM QUALITY; STEROIDOGENESIS; TESTIS DEVELOPMENT; TESTIS DISEASE; TESTOSTERONE RELEASE;

EID: 84930944040     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2015.00058     Document Type: Review

References (157)

1. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette LJ Jr, et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect (1996) 104(Suppl 4):741-803. doi: 10.2307/3432709
2. Sharpe RM, Irvine DS. How strong is the evidence of a link between environmental chemicals and adverse effects on human reproductive health? BMJ (2004) 328:447-51. doi:10.1136/bmj.328.7437.447
3. Rucker EB III, Dierisseau P, Wagner KU, Garrett L, Wynshaw-Boris A, Flaws JA, et al. Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis. Mol Endocrinol (2000) 14:1038-52. doi:10.1210/mend.14.7.0465
4. Lu B, Bishop CE. Late onset of spermatogenesis and gain of fertility in POG-deficient mice indicate that POG is not necessary for the proliferation of spermatogonia. Biol Reprod (2003) 69:161-8. doi:10.1095/biolreprod.102.014654
5. Forand A, Messiaen S, Habert R, Bernardino-Sgherri J. Exposure of the mouse perinatal testis to radiation leads to hypospermia at sexual maturity. Reproduction (2009) 137:487-95. doi:10.1530/REP-08-0358
6. Habert R, Lejeune H, Saez JM. Origin, differentiation and regulation of fetal and adult Leydig cells. Mol Cell Endocrinol (2001) 179:47-74. doi:10.1016/S0303-7207(01)00461-0
7. Scott HM, Mason JI, Sharpe RM. Steroidogenesis in the fetal testis and its susceptibility to disruption by exogenous compounds. Endocr Rev (2009) 30:883-925. doi:10.1210/er.2009-0016
8. Welsh M, Suzuki H, Yamada G. The masculinization programming window. Endocr Dev (2014) 27:17-27. doi:10.1159/000363609
9. Kilcoyne KR, Smith LB, Atanassova N, Macpherson S, Mckinnell C, Van Den Driesche S, et al. Fetal programming of adult leydig cell function by androgenic effects on stem/progenitor cells. Proc Natl Acad Sci U S A (2014) 111:E1924-32. doi:10.1073/pnas.1320735111
10. Bay K, Main KM, Toppari J, Skakkebaek NE. Testicular descent: INSL3, testosterone, genes and the intrauterine milieu. Nat Rev Urol (2011) 8:187-96. doi:10.1038/nrurol.2011.23
11. Ivell R, Heng K, Anand-Ivell R. Insulin-like factor 3 and the HPG axis in the male. Front Endocrinol (2014) 5:6.
12. Sharpe RM, Skakkebaek NE. Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil Steril (2008) 89:e33-8. doi:10.1016/j.fertnstert.2007.12.026
13. Main KM, Skakkebaek NE, Virtanen HE, Toppari J. Genital anomalies in boys and the environment. Best Pract Res Clin Endocrinol Metab (2010) 24:279-89. doi:10.1016/j.beem.2009.10.003
14. Delbes G, Levacher C, Habert R. Estrogen effects on fetal and neonatal testicular development. Reproduction (2006) 132:527-38. doi:10.1530/rep.1.01231
15. Livera G, Delbes G, Pairault C, Rouiller-Fabre V, Habert R. Organotypic culture, a powerful model for studying rat and mouse fetal testis development. Cell Tissue Res (2006) 324:507-21. doi:10.1007/s00441-006-0167-7
16. Habert R, Muczynski V, Lehraiki A, Lambrot R, Lecureuil C, Levacher C, et al. Adverse effects of endocrine disruptors on the foetal testis development: focus on the phthalates. Folia Histochem Cytobiol (2009) 47:S67-74. doi:10.2478/v10042-009-0056-5
17. Eladak S, Grisin T, Moison D, Guerquin MJ, N'tumba-Byn T, Pozzi-Gaudin S, et al. A new chapter in the bisphenol A story: bisphenol S and bisphenol F are not safe alternatives to this compound. Fertil Steril (2015) 103:11-21. doi:10.1016/j.fertnstert.2014.11.005
18. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (1986) 320:134-9. doi:10.1038/320134a0
19. Koike S, Sakai M, Muramatsu M. Molecular cloning and characterization of rat estrogen receptor cDNA. Nucleic Acids Res (1987) 15:2499-513. doi:10.1093/nar/15.6.2499
20. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A (1996) 93:5925-30. doi:10.1073/pnas.93.12.5925
21. Nuclear Receptors Nomenclature C. A unified nomenclature system for the nuclear receptor superfamily. Cell (1999) 97:161-3. doi:10.1016/S0092-8674(00)80726-6
22. Williams K, Mckinnell C, Saunders PT, Walker M, Fisher JS, Turner KJ, et al. Neonatal exposure to potent and environmental oestrogens and abnormalities of the male reproductive system in the rat: evidence for importance of the androgen-oestrogen balance and assessment of the relevance to man. Hum Reprod Update (2001) 7:236-47. doi:10.1093/humupd/7.3.236
23. Greco TL, Furlow JD, Duello TM, Gorski J. Immunodetection of estrogen receptors in fetal and neonatal male mouse reproductive tracts. Endocrinology (1992) 130:421-9. doi:10.1210/en.130.1.421
24. Nielsen M, Bjornsdottir S, Hoyer PE, Byskov AG. Ontogeny of oestrogen receptor alpha in gonads and sex ducts of fetal and newborn mice. J Reprod Fertil (2000) 118:195-204. doi:10.1530/jrf.0.1180195
25. Delbes G, Levacher C, Duquenne C, Racine C, Pakarinen P, Habert R. Endogenous estrogens inhibit mouse fetal leydig cell development via estrogen receptor alpha. Endocrinology (2005) 146:2454-61. doi:10.1210/en.2004-1540
26. Jefferson WN, Couse JF, Banks EP, Korach KS, Newbold RR. Expression of estrogen receptor beta is developmentally regulated in reproductive tissues of male and female mice. Biol Reprod (2000) 62:310-7. doi:10.1095/biolreprod62.2.310
27. Saunders PT, Fisher JS, Sharpe RM, Millar MR. Expression of oestrogen receptor beta (ER beta) occurs in multiple cell types, including some germ cells, in the rat testis. J Endocrinol (1998) 156:R13-7. doi:10.1677/joe.0.156R013
28. van Pelt AM, De Rooij DG, Van Der Burg B, Van Der Saag PT, Gustafsson JA, Kuiper GG. Ontogeny of estrogen receptor-beta expression in rat testis. Endocrinology (1999) 140:478-83. doi:10.1210/en.140.1.478
29. Brandenberger AW, Tee MK, Lee JY, Chao V, Jaffe RB. Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus. J Clin Endocrinol Metab (1997) 82:3509-12. doi:10.1210/jcem.82.10.4400
30. Saunders PT, Millar MR, Macpherson S, Irvine DS, Groome NP, Evans LR, et al. ERbeta1 and the ERbeta2 splice variant (ERbetacx/beta2) are expressed in distinct cell populations in the adult human testis. J Clin Endocrinol Metab (2002) 87:2706-15. doi:10.1210/jcem.87.6.8619
31. Takeyama J, Suzuki T, Inoue S, Kaneko C, Nagura H, Harada N, et al. Expression and cellular localization of estrogen receptors alpha and beta in the human fetus. J Clin Endocrinol Metab (2001) 86:2258-62. doi:10.1210/jcem.86.5.7447
32. Gaskell TL, Robinson LL, Groome NP, Anderson RA, Saunders PT. Differential expression of two estrogen receptor beta isoforms in the human fetal testis during the second trimester of pregnancy. J Clin Endocrinol Metab (2003) 88:424-32. doi:10.1210/jc.2002-020811
33. Mitchell RT, Sharpe RM, Anderson RA, Mckinnell C, Macpherson S, Smith LB, et al. Diethylstilboestrol exposure does not reduce testosterone production in human fetal testis xenografts. PLoS One (2013) 8:e61726. doi:10.1371/journal.pone.0061726
34. Pelletier G, El-Alfy M. Immunocytochemical localization of estrogen receptors alpha and beta in the human reproductive organs. J Clin Endocrinol Metab (2000) 85:4835-40. doi:10.1210/jcem.85.12.7029
35. Korach KS. Insights from the study of animals lacking functional estrogen receptor. Science (1994) 266:1524-7. doi:10.1126/science.7985022
36. Fisher CR, Graves KH, Parlow AF, Simpson ER. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci U S A (1998) 95:6965-70. doi:10.1073/pnas.95.12.6965
37. Robertson KM, O'donnell L, Jones ME, Meachem SJ, Boon WC, Fisher CR, et al. Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. Proc Natl Acad Sci U S A (1999) 96:7986-91. doi:10.1073/pnas.96.14.7986
38. O'Donnell L, Robertson KM, Jones ME, Simpson ER. Estrogen and spermatogenesis. Endocr Rev (2001) 22:289-318. doi:10.1210/edrv.22.3.0431
39. Delbes G, Levacher C, Pairault C, Racine C, Duquenne C, Krust A, et al. Estrogen receptor beta-mediated inhibition of male germ cell line development in mice by endogenous estrogens during perinatal life. Endocrinology (2004) 145:3395-403. doi:10.1210/en.2003-1479
40. Carreau S, Wolczynski S, Galeraud-Denis I. Aromatase, oestrogens and human male reproduction. Philos Trans R Soc Lond B Biol Sci (2010) 365:1571-9. doi:10.1098/rstb.2009.0113
41. Smith LB, Walker WH. The regulation of spermatogenesis by androgens. Semin Cell Dev Biol (2014) 30:2-13. doi:10.1016/j.semcdb.2014.02.012
42. Zhou Q, Nie R, Prins GS, Saunders PT, Katzenellenbogen BS, Hess RA. Localization of androgen and estrogen receptors in adult male mouse reproductive tract. J Androl (2002) 23:870-81.
43. Merlet J, Racine C, Moreau E, Moreno SG, Habert R. Male fetal germ cells are targets for androgens that physiologically inhibit their proliferation. Proc Natl Acad Sci U S A (2007) 104:3615-20. doi:10.1073/pnas.0611421104
44. Merlet J, Moreau E, Habert R, Racine C. Development of fetal testicular cells in androgen receptor deficient mice. Cell Cycle (2007) 6:2258-62. doi:10.4161/cc.6.18.4654
45. Sharpe RM, Mckinnell C, Kivlin C, Fisher JS. Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction (2003) 125:769-84. doi:10.1530/rep.0.1250769
46. Boukari K, Meduri G, Brailly-Tabard S, Guibourdenche J, Ciampi ML, Massin N, et al. Lack of androgen receptor expression in sertoli cells accounts for the absence of anti-mullerian hormone repression during early human testis development. J Clin Endocrinol Metab (2009) 94:1818-25. doi:10.1210/jc.2008-1909
47. O'Hara L, Mcinnes K, Simitsidellis I, Morgan S, Atanassova N, Slowikowska-Hilczer J, et al. Autocrine androgen action is essential for Leydig cell maturation and function, and protects against late-onset leydig cell apoptosis in both mice and men. FASEB J (2015) 29:894-910. doi:10.1096/fj.14-255729
48. Connolly F, Rae MT, Bittner L, Hogg K, Mcneilly AS, Duncan WC. Excess androgens in utero alters fetal testis development. Endocrinology (2013) 154:1921-33. doi:10.1210/en.2012-2153
49. Rojas-Garcia PP, Recabarren MP, Sir-Petermann T, Rey R, Palma S, Carrasco A, et al. Altered testicular development as a consequence of increase number of sertoli cell in male lambs exposed prenatally to excess testosterone. Endocrine (2013) 43:705-13. doi:10.1007/s12020-012-9818-5
50. Berger JP, Akiyama TE, Meinke PT. PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci (2005) 26:244-51. doi:10.1016/j.tips.2005.03.003
51. Froment P, Gizard F, Defever D, Staels B, Dupont J, Monget P. Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition. J Endocrinol (2006) 189:199-209. doi:10.1677/joe.1.06667
52. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology (1996) 137:354-66. doi:10.1210/endo.137.1.8536636
53. Lapinskas PJ, Brown S, Leesnitzer LM, Blanchard S, Swanson C, Cattley RC, et al. Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver. Toxicology (2005) 207:149-63. doi:10.1016/j.tox.2004.09.008
54. Marugo M, Aste H, Bernasconi D, Fazzuoli L, Conio M, Cuva A, et al. Cytosolic and nuclear androgen receptors in colorectal adenomas. Anticancer Res (1992) 12:705-8.
55. Muczynski V, Lecureuil C, Messiaen S, Guerquin M, N'tumba-Byn T, Moison D, et al. Cellular and molecular effect of MEHP Involving LXRalpha in human fetal testis and ovary. PLoS One (2012) 7:e48266. doi:10.1371/journal.pone.0048266
56. Hase T, Yoshimura R, Mitsuhashi M, Segawa Y, Kawahito Y, Wada S, et al. Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists. Urology (2002) 60:542-7. doi:10.1016/S0090-4295(02)01747-8
57. Ward JM, Peters JM, Perella CM, Gonzalez FJ. Receptor and nonreceptor-mediated organ-specific toxicity of di(2-ethylhexyl)phthalate (DEHP) in peroxisome proliferator-activated receptor alpha-null mice. Toxicol Pathol (1998) 26:240-6. doi:10.1177/019262339802600208
58. Hannas BR, Lambright CS, Furr J, Evans N, Foster PM, Gray EL, et al. Genomic biomarkers of phthalate-induced male reproductive developmental toxicity: a targeted RT-PCR array approach for defining relative potency. Toxicol Sci (2012) 125:544-57. doi:10.1093/toxsci/kfr315
59. Regueira M, Riera MF, Galardo MN, Pellizzari EH, Cigorraga SB, Meroni SB. Activation of PPAR alpha and PPAR beta/delta regulates sertoli cell metabolism. Mol Cell Endocrinol (2014) 382:271-81. doi:10.1016/j.mce.2013.10.006
60. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell (1999) 4:585-95. doi:10.1016/S1097-2765(00)80209-9
61. Thomas K, Sung DY, Chen X, Thompson W, Chen YE, Mccarrey J, et al. Developmental patterns of PPAR and RXR gene expression during spermatogenesis. Front Biosci (Elite Ed) (2011) 3:1209-20.
62. Lu TT, Repa JJ, Mangelsdorf DJ. Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J Biol Chem (2001) 276:37735-8. doi:10.1074/jbc.R100035200
63. Cao G, Liang Y, Jiang XC, Eacho PI. Liver X receptors as potential therapeutic targets for multiple diseases. Drug News Perspect (2004) 17:35-41. doi:10.1358/dnp.2004.17.1.829024
64. El-Hajjaji FZ, Oumeddour A, Pommier AJ, Ouvrier A, Viennois E, Dufour J, et al. Liver X receptors, lipids and their reproductive secrets in the male. Biochim Biophys Acta (2011) 1812:974-81. doi:10.1016/j.bbadis.2011.02.004
65. Volle DH, Mouzat K, Duggavathi R, Siddeek B, Dechelotte P, Sion B, et al. Multiple roles of the nuclear receptors for oxysterols liver X receptor to maintain male fertility. Mol Endocrinol (2007) 21:1014-27. doi:10.1210/me.2006-0277
66. Volle DH, Lobaccaro JM. Role of the nuclear receptors for oxysterols LXRs in steroidogenic tissues: beyond the "foie gras", the steroids and sex? Mol Cell Endocrinol (2007) 26(5-266):183-9. doi:10.1016/j.mce.2006.12.018
67. Oumeddour A, Viennois E, Caira F, Decourbey C, Maqdasy S, Tahraoui A, et al. Liver X receptors interfere with the deleterious effect of diethylstilbestrol on testicular physiology. Biochem Biophys Res Commun (2014) 446:656-62. doi:10.1016/j.bbrc.2013.12.005
68. Rondanino C, Ouchchane L, Chauffour C, Marceau G, Dechelotte P, Sion B, et al. Levels of liver X receptors in testicular biopsies of patients with azoospermia. Fertil Steril (2014) 102(361-371):e365. doi:10.1016/j.fertnstert.2014.04.033
69. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell (2000) 6:507-15. doi:10.1016/S1097-2765(00)00050-2
70. Kerr TA, Saeki S, Schneider M, Schaefer K, Berdy S, Redder T, et al. Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev Cell (2002) 2:713-20. doi:10.1016/S1534-5807(02)00154-5
71. Volle DH, Duggavathi R, Magnier BC, Houten SM, Cummins CL, Lobaccaro JM, et al. The small heterodimer partner is a gonadal gatekeeper of sexual maturation in male mice. Genes Dev (2007) 21:303-15. doi:10.1101/gad.409307
72. Maqdasy S, Baptissart M, Vega A, Baron S, Lobaccaro JM, Volle DH. Cholesterol and male fertility: what about orphans and adopted? Mol Cell Endocrinol (2013) 368:30-46. doi:10.1016/j.mce.2012.06.011
73. Bowles J, Knight D, Smith C, Wilhelm D, Richman J, Mamiya S, et al. Retinoid signaling determines germ cell fate in mice. Science (2006) 312:596-600. doi:10.1126/science.1125691
74. Koubova J, Menke DB, Zhou Q, Capel B, Griswold MD, Page DC. Retinoic acid regulates sex-specific timing of meiotic initiation in mice. Proc Natl Acad Sci U S A (2006) 103:2474-9. doi:10.1073/pnas.0510813103
75. Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet (1993) 341:1392-5. doi:10.1016/0140-6736(93)90953-E
76. Glaze GM. Diethylstilbestrol exposure in utero: review of literature. J Am Osteopath Assoc (1984) 83:435-8.
77. Strohsnitter WC, Noller KL, Hoover RN, Robboy SJ, Palmer JR, Titus-Ernstoff L, et al. Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst (2001) 93:545-51. doi:10.1093/jnci/93.7.545
78. Storgaard L, Bonde JP, Olsen J. Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies. Reprod Toxicol (2006) 21:4-15. doi:10.1016/j.reprotox.2005.05.006
79. Sharpe RM. The 'oestrogen hypothesis' - where do we stand now? Int J Androl (2003) 26:2-15. doi:10.1046/j.1365-2605.2003.00367.x
80. Yasuda Y, Kihara T, Tanimura T. Effect of ethinyl estradiol on the differentiation of mouse fetal testis. Teratology (1985) 32:113-8. doi:10.1002/tera.1420320115
81. Yasuda Y, Kihara T, Tanimura T, Nishimura H. Gonadal dysgenesis induced by prenatal exposure to ethinyl estradiol in mice. Teratology (1985) 32:219-27. doi:10.1002/tera.1420320210
82. Perez-Martinez C, Garcia-Iglesias MJ, Ferreras-Estrada MC, Bravo-Moral AM, Espinosa-Alvarez J, Escudero-Diez A. Effects of in-utero exposure to zeranol or diethylstilboestrol on morphological development of the fetal testis in mice. J Comp Pathol (1996) 114:407-18. doi:10.1016/S0021-9975(96)80016-8
83. Lassurguere J, Livera G, Habert R, Jegou B. Time- and dose-related effects of estradiol and diethylstilbestrol on the morphology and function of the fetal rat testis in culture. Toxicol Sci (2003) 73:160-9. doi:10.1093/toxsci/kfg065
84. Delbes G, Duquenne C, Szenker J, Taccoen J, Habert R, Levacher C. Developmental changes in testicular sensitivity to estrogens throughout fetal and neonatal life. Toxicol Sci (2007) 99:234-43. doi:10.1093/toxsci/kfm160
85. Guyot R, Odet F, Leduque P, Forest MG, Le Magueresse-Battistoni B. Diethylstilbestrol inhibits the expression of the steroidogenic acute regulatory protein in mouse fetal testis. Mol Cell Endocrinol (2004) 220:67-75. doi:10.1016/j.mce.2004.03.008
86. Cederroth CR, Schaad O, Descombes P, Chambon P, Vassalli JD, Nef S. Estrogen receptor alpha is a major contributor to estrogen-mediated fetal testis dysgenesis and cryptorchidism. Endocrinology (2007) 148:5507-19. doi:10.1210/en.2007-0689
87. Lundholm L, Moverare S, Steffensen KR, Nilsson M, Otsuki M, Ohlsson C, et al. Gene expression profiling identifies liver X receptor alpha as an estrogen-regulated gene in mouse adipose tissue. J Mol Endocrinol (2004) 32:879-92. doi:10.1677/jme.0.0320879
88. Gong H, Guo P, Zhai Y, Zhou J, Uppal H, Jarzynka MJ, et al. Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol Endocrinol (2007) 21:1781-90. doi:10.1210/me.2007-0187
89. Volle DH, Decourteix M, Garo E, Mcneilly J, Fenichel P, Auwerx J, et al. The orphan nuclear receptor small heterodimer partner mediates male infertility induced by diethylstilbestrol in mice. J Clin Invest (2009) 119:3752-64. doi:10.1172/JCI38521
90. N'Tumba-Byn T, Moison D, Lacroix M, Lecureuil C, Lesage L, Prud'homme S, et al. Differential effects of bisphenol A and diethylstilbestrol on human, rat and mouse fetal leydig cell function. PLoS One (2012) 7:e51579. doi:10.1371/journal.pone.0051579
91. Latini G, Del Vecchio A, Massaro M, Verrotti A, DE Felice C. In utero exposure to phthalates and fetal development. Curr Med Chem (2006) 13:2527-34. doi:10.2174/092986706778201666
92. Fisher JS. Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome. Reproduction (2004) 127:305-15. doi:10.1530/rep.1.00025
93. Chauvigne F, Menuet A, Lesne L, Chagnon MC, Chevrier C, Regnier JF, et al. Time- and dose-related effects of di-(2-ethylhexyl) phthalate and its main metabolites on the function of the rat fetal testis in vitro. Environ Health Perspect (2009) 117:515-21. doi:10.1289/ehp.11870
94. Lambrot R, Muczynski V, Lecureuil C, Angenard G, Coffigny H, Pairault C, et al. Phthalates impair germ cell development in the human fetal testis in vitro without change in testosterone production. Environ Health Perspect (2009) 117:32-7. doi:10.1289/ehp.11146
95. Lehraiki A, Racine C, Krust A, Habert R, Levacher C. Phthalates impair germ cell number in the mouse fetal testis by an androgen- and estrogen-independent mechanism. Toxicol Sci (2009) 111:372-82. doi:10.1093/toxsci/kfp153
96. Swan SH, Main KM, Liu F, Stewart SL, Kruse RL, Calafat AM, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect (2005) 113:1056-61. doi:10.1289/ehp.8100
97. Huang PC, Kuo PL, Chou YY, Lin SJ, Lee CC. Association between prenatal exposure to phthalates and the health of newborns. Environ Int (2009) 35:14-20. doi:10.1016/j.envint.2008.05.012
98. Fisher JS, Macpherson S, Marchetti N, Sharpe RM. Human 'testicular dysgenesis syndrome': a possible model using in-utero exposure of the rat to dibutyl phthalate. Hum Reprod (2003) 18:1383-94. doi:10.1093/humrep/deg273
99. Habert R, Livera G, Rouiller-Fabre V. Man is not a big rat: concerns with traditional human risk assessment of phthalates based on their anti-androgenic effects observed in the rat foetus. Basic Clin Androl (2014) 24:14. doi:10.1186/2051-4190-24-14
100. Habert R, Muczynski V, Grisin T, Moison D, Messiaen S, Frydman R, et al. Concerns about the widespread use of rodent models for human risk assessments of endocrine disruptors. Reproduction (2014) 147:R119-29. doi:10.1530/REP-13-0497
101. Heger NE, Hall SJ, Sandrof MA, Mcdonnell EV, Hensley JB, Mcdowell EN, et al. Human fetal testis xenografts are resistant to phthalate-induced endocrine disruption. Environ Health Perspect (2012) 120:1137-43. doi:10.1289/ehp.1104711
102. Mitchell RT, Childs AJ, Anderson RA, Van Den Driesche S, Saunders PT, Mckinnell C, et al. Do phthalates affect steroidogenesis by the human fetal testis? Exposure of human fetal testis xenografts to di-n-butyl phthalate. J Clin Endocrinol Metab (2012) 97:E341-8. doi:10.1210/jc.2011-2411
103. Spade DJ, Hall SJ, Saffarini CM, Huse SM, Mcdonnell EV, Boekelheide K. Differential response to abiraterone acetate and di-n-butyl phthalate in an androgen-sensitive human fetal testis xenograft bioassay. Toxicol Sci (2014) 138:148-60. doi:10.1093/toxsci/kft266
104. Barlow NJ, Phillips SL, Wallace DG, Sar M, Gaido KW, Foster PM. Quantitative changes in gene expression in fetal rat testes following exposure to di(n-butyl) phthalate. Toxicol Sci (2003) 73:431-41. doi:10.1093/toxsci/kfg087
105. Ferrara D, Hallmark N, Scott H, Brown R, Mckinnell C, Mahood IK, et al. Acute and long-term effects of in utero exposure of rats to di(n-butyl) phthalate on testicular germ cell development and proliferation. Endocrinology (2006) 147:5352-62. doi:10.1210/en.2006-0527
106. Latini G, Scoditti E, Verrotti A, De Felice C, Massaro M. Peroxisome proliferator-activated receptors as mediators of phthalate-induced effects in the male and female reproductive tract: epidemiological and experimental evidence. PPAR Res (2008) 2008:359267. doi:10.1155/2008/359267
107. Rusyn I, Peters JM, Cunningham ML. Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. Crit Rev Toxicol (2006) 36:459-79. doi:10.1080/10408440600779065
108. Hurst CH, Waxman DJ. Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol Sci (2003) 74:297-308. doi:10.1093/toxsci/kfg145
109. Maloney EK, Waxman DJ. Trans-activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals. Toxicol Appl Pharmacol (1999) 161:209-18. doi:10.1006/taap.1999.8809
110. Hurst CH, Waxman DJ. Environmental phthalate monoesters activate pregnane X receptor-mediated transcription. Toxicol Appl Pharmacol (2004) 199:266-74. doi:10.1016/j.taap.2003.11.028
111. Euling SY, White LD, Kim AS, Sen B, Wilson VS, Keshava C, et al. Use of genomic data in risk assessment case study: II. Evaluation of the dibutyl phthalate toxicogenomic data set. Toxicol Appl Pharmacol (2013) 271:349-62. doi:10.1016/j.taap.2011.06.014
112. Borch J, Metzdorff SB, Vinggaard AM, Brokken L, Dalgaard M. Mechanisms underlying the anti-androgenic effects of diethylhexyl phthalate in fetal rat testis. Toxicology (2006) 223:144-55. doi:10.1016/j.tox.2006.03.015
113. Boberg J, Metzdorff S, Wortziger R, Axelstad M, Brokken L, Vinggaard AM, et al. Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats. Toxicology (2008) 250:75-81. doi:10.1016/j.tox.2008.05.020
114. Ryu JY, Whang J, Park H, Im JY, Kim J, Ahn MY, et al. Di(2-ethylhexyl) phthalate induces apoptosis through peroxisome proliferators-activated receptor-gamma and ERK 1/2 activation in testis of Sprague-Dawley rats. J Toxicol Environ Health A (2007) 70:1296-303. doi:10.1080/15287390701432160
115. Klinefelter GR, Laskey JW, Winnik WM, Suarez JD, Roberts NL, Strader LF, et al. Novel molecular targets associated with testicular dysgenesis induced by gestational exposure to diethylhexyl phthalate in the rat: a role for estradiol. Reproduction (2012) 144:747-61. doi:10.1530/REP-12-0266
116. Muczynski V, Cravedi JP, Lehraiki A, Levacher C, Moison D, Lecureuil C, et al. Effect of mono-(2-ethylhexyl) phthalate on human and mouse fetal testis: in vitro and in vivo approaches. Toxicol Appl Pharmacol (2012) 261:97-104. doi:10.1016/j.taap.2012.03.016
117. Dodds EC, Lawson W. Synthetic oestrogenic agents without the phenanthrene nucleus. Nature (1936) 137:996. doi:10.1038/137996a0
118. Vandenberg LN, Maffini MV, Wadia PR, Sonnenschein C, Rubin BS, Soto AM. Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology (2007) 148:116-27. doi:10.1210/en.2006-0561
119. Zalko D, Jacques C, Duplan H, Bruel S, Perdu E. Viable skin efficiently absorbs and metabolizes bisphenol A. Chemosphere (2011) 82:424-30. doi:10.1016/j.chemosphere.2010.09.058
120. Rochester JR. Bisphenol A and human health: a review of the literature. Reprod Toxicol (2013) 42:132-55. doi:10.1016/j.reprotox.2013.08.008
121. Miao M, Yuan W, He Y, Zhou Z, Wang J, Gao E, et al. In utero exposure to bisphenol-A and anogenital distance of male offspring. Birth Defects Res A Clin Mol Teratol (2011) 91:867-72. doi:10.1002/bdra.22845
122. Choi H, Kim J, Im Y, Lee S, Kim Y. The association between some endocrine disruptors and hypospadias in biological samples. J Environ Sci Health A Tox Hazard Subst Environ Eng (2012) 47:2173-9. doi:10.1080/10934529.2012.680387
123. Fenichel P, Dechaux H, Harthe C, Gal J, Ferrari P, Pacini P, et al. Unconjugated bisphenol A cord blood levels in boys with descended or undescended testes. Hum Reprod (2012) 27:983-90. doi:10.1093/humrep/der451
124. Fenichel P, Chevalier N, Brucker-Davis F. Bisphenol A: an endocrine and metabolic disruptor. Ann Endocrinol (Paris) (2013) 74:211-20. doi:10.1016/j.ando.2013.04.002
125. Tanaka M, Nakaya S, Katayama M, Leffers H, Nozawa S, Nakazawa R, et al. Effect of prenatal exposure to bisphenol A on the serum testosterone concentration of rats at birth. Hum Exp Toxicol (2006) 25:369-73. doi:10.1191/0960327106ht638oa
126. Murray TJ, Maffini MV, Ucci AA, Sonnenschein C, Soto AM. Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. Reprod Toxicol (2007) 23:383-90. doi:10.1016/j.reprotox.2006.10.002
127. Kobayashi K, Miyagawa M, Wang RS, Sekiguchi S, Suda M, Honma T. Effects of in utero and lactational exposure to bisphenol A on somatic growth and anogenital distance in F1 rat offspring. Ind Health (2002) 40:375-81. doi:10.2486/indhealth.40.375
128. Tyl RW, Myers CB, Marr MC, Thomas BF, Keimowitz AR, Brine DR, et al. Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicol Sci (2002) 68:121-46. doi:10.1093/toxsci/68.1.121
129. Howdeshell KL, Furr J, Lambright CR, Wilson VS, Ryan BC, Gray LE Jr. Gestational and lactational exposure to ethinyl estradiol, but not bisphenol A, decreases androgen-dependent reproductive organ weights and epididymal sperm abundance in the male long evans hooded rat. Toxicol Sci (2008) 102:371-82. doi:10.1093/toxsci/kfm306
130. LaRocca J, Boyajian A, Brown C, Smith SD, Hixon M. Effects of in utero exposure to bisphenol A or diethylstilbestrol on the adult male reproductive system. Birth Defects Res B Dev Reprod Toxicol (2011) 92:526-33. doi:10.1002/bdrb.20336
131. Salian S, Doshi T, Vanage G. Perinatal exposure of rats to bisphenol A affects the fertility of male offspring. Life Sci (2009) 85:742-52. doi:10.1016/j.lfs.2009.10.004
132. Zhang HQ, Zhang XF, Zhang LJ, Chao HH, Pan B, Feng YM, et al. Fetal exposure to bisphenol A affects the primordial follicle formation by inhibiting the meiotic progression of oocytes. Mol Biol Rep (2012) 39:5651-7. doi:10.1007/s11033-011-1372-3
133. Molina-Molina JM, Amaya E, Grimaldi M, Saenz JM, Real M, Fernandez MF, et al. In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors. Toxicol Appl Pharmacol (2013) 272:127-36. doi:10.1016/j.taap.2013.05.015
134. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, Van Der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology (1998) 139:4252-63. doi:10.1210/endo.139.10.6216
135. Boukari K, Ciampi ML, Guiochon-Mantel A, Young J, Lombes M, Meduri G. Human fetal testis: source of estrogen and target of estrogen action. Hum Reprod (2007) 22:1885-92. doi:10.1093/humrep/dem091
136. Paris F, Balaguer P, Terouanne B, Servant N, Lacoste C, Cravedi JP, et al. Phenylphenols, biphenols, bisphenol-A and 4-tert-octylphenol exhibit alpha and beta estrogen activities and antiandrogen activity in reporter cell lines. Mol Cell Endocrinol (2002) 193:43-9. doi:10.1016/S0303-7207(02)00094-1
137. Riu A, Grimaldi M, Le Maire A, Bey G, Phillips K, Boulahtouf A, et al. Peroxisome proliferator-activated receptor gamma is a target for halogenated analogs of bisphenol A. Environ Health Perspect (2011) 119:1227-32. doi:10.1289/ehp.1003328
138. Riu A, Le Maire A, Grimaldi M, Audebert M, Hillenweck A, Bourguet W, et al. Characterization of novel ligands of ERalpha, Erbeta, and PPARgamma: the case of halogenated bisphenol A and their conjugated metabolites. Toxicol Sci (2011) 122:372-82. doi:10.1093/toxsci/kfr132
139. Pereira-Fernandes A, Demaegdt H, Vandermeiren K, Hectors TL, Jorens PG, Blust R, et al. Evaluation of a screening system for obesogenic compounds: screening of endocrine disrupting compounds and evaluation of the PPAR dependency of the effect. PLoS One (2013) 8:e77481. doi:10.1371/journal.pone.0077481
140. Helies-Toussaint C, Peyre L, Costanzo C, Chagnon MC, Rahmani R. Is bisphenol S a safe substitute for bisphenol A in terms of metabolic function? An in vitro study. Toxicol Appl Pharmacol (2014) 280:224-35. doi:10.1016/j.taap.2014.07.025
141. Somm E, Schwitzgebel VM, Toulotte A, Cederroth CR, Combescure C, Nef S, et al. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ Health Perspect (2009) 117:1549-55. doi:10.1289/ehp.11342
142. Marmugi A, Ducheix S, Lasserre F, Polizzi A, Paris A, Priymenko N, et al. Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology (2012) 55:395-407. doi:10.1002/hep.24685
143. Colborn T, Vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect (1993) 101:378-84. doi:10.1289/ehp.93101378
144. Sonnenschein C, Soto AM. An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol (1998) 65:143-50. doi:10.1016/S0960-0760(98)00027-2
145. Edwards TM, Moore BC, Guillette LJ Jr. Reproductive dysgenesis in wildlife: a comparative view. Int J Androl (2006) 29:109-21. doi:10.1111/j.1365-2605.2005.00631.x
146. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee DH, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev (2012) 33:378-455. doi:10.1210/er.2011-1050
147. Vandenberg LN. Non-monotonic dose responses in studies of endocrine disrupting chemicals: bisphenol a as a case study. Dose Response (2014) 12:259-76. doi:10.2203/dose-response.13-020.Vandenberg
148. Xiao-feng Z, Nai-Qiang Q, Jing Z, Zi L, Yang Z. Di (n-butyl) phthalate inhibits testosterone synthesis through a glucocorticoid-mediated pathway in rats. Int J Toxicol (2009) 28:448-56. doi:10.1177/1091581809342596
149. Martinez-Arguelles DB, Culty M, Zirkin BR, Papadopoulos V. In utero exposure to di-(2-ethylhexyl) phthalate decreases mineralocorticoid receptor expression in the adult testis. Endocrinology (2009) 150:5575-85. doi:10.1210/en.2009-0847
150. Okada H, Tokunaga T, Liu X, Takayanagi S, Matsushima A, Shimohigashi Y. Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma. Environ Health Perspect (2008) 116:32-8. doi:10.1289/ehp.10587
151. Levin ER. Minireview: extranuclear steroid receptors: roles in modulation of cell functions. Mol Endocrinol (2011) 25:377-84. doi:10.1210/me.2010-0284
152. Bouskine A, Nebout M, Brucker-Davis F, Benahmed M, Fenichel P. Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor. Environ Health Perspect (2009) 117:1053-8. doi:10.1289/ehp.0800367
153. Chevalier N, Vega A, Bouskine A, Siddeek B, Michiels JF, Chevallier D, et al. GPR30, the non-classical membrane G protein related estrogen receptor, is overexpressed in human seminoma and promotes seminoma cell proliferation. PLoS One (2012) 7:e34672. doi:10.1371/journal.pone.0034672
154. Tohme M, Prud'homme SM, Boulahtouf A, Samarut E, Brunet F, Bernard L, et al. Estrogen-related receptor gamma is an in vivo receptor of bisphenol A. FASEB J (2014) 28:3124-33. doi:10.1096/fj.13-240465
155. Takayanagi S, Tokunaga T, Liu X, Okada H, Matsushima A, Shimohigashi Y. Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor gamma (ERRgamma) with high constitutive activity. Toxicol Lett (2006) 167:95-105. doi:10.1016/j.toxlet.2006.08.012
156. Delfosse V, Grimaldi M, Le Maire A, Bourguet W, Balaguer P. Nuclear receptor profiling of bisphenol-A and its halogenated analogues. Vitam Horm (2014) 94:229-51. doi:10.1016/B978-0-12-800095-3.00009-2
157. Lonard DM, O'Malley BW. The expanding cosmos of nuclear receptor coactivators. Cell (2006) 125:411-4. doi:10.1016/j.cell.2006.04.021